Mexico kicks off Covid vaccination campaign with Pfizer-BioNTech candidate

Pfizer Covid-19 vaccine

Mexico has kicked off its vaccination campaign against the novel coronavirus, with a vaccine developed by US laboratory Pfizer and its German partner BioNTech.

With healthcare workers prioritized, the first person to be vaccinated on Thursday was Maria Irene Ramirez, head of nursing at the intensive care unit of the Ruben Lenero Hospital in Mexico City, the capital and one of the regions hit the worst by the pandemic, with 302,199 confirmed cases and 20,472 deaths, reports Xinhua news agency.

At the launch ceremony, Deputy Health Minister Hugo Lopez-Gatell noted that while the pandemic is not over, "with the vaccine it will be possible to combat it more effectively".

"Today, December 24, vaccination against Covid-19 begins and today the management of the pandemic changes with a light of hope," said Lopez-Gatell during the event, which was broadcast live as part of Mexican President Andres Manuel Lopez Obrador's daily morning press conference.

Vaccination began a day after the first 3,000 doses arrived from Pfizer-BioNTech laboratories, the first of 1.4 million doses expected to be delivered by January 31, 2021.

Mexico currently accounts for the world's fourth highest coronavirus death toll and the 13th largest caseload.

As of Friday, the country's overall confirmed cases and deaths stood at 1,350,079 and 121,172, respectively.

--IANS

ksk/

 


(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)


Dear Reader,


Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.

We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor

Business Standard is now on Telegram.
For insightful reports and views on business, markets, politics and other issues, subscribe to our official Telegram channel